Caitong International Asset Management’s CAMP4 Therapeutics CAMP Stock Holding History

Caitong International Asset Management’s Portfolio CAMP Stock Details CAMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$326	Buy	+74	New	+$351	﹤0.01%	1772

Other funds holding CAMP

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

ACM

AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $437M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Caitong International Asset Management's CAMP Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in CAMP4 Therapeutics (CAMP) in Q1 2026: 74 shares worth $326. The stake represents ﹤0.01% of the portfolio and ranks #1772 among its holdings.

46 funds tracked by Wall St. Rank hold CAMP as of Q1 2026.

Caitong International Asset Management held 74 shares of CAMP4 Therapeutics worth $326 as of Q1 2026.
CAMP4 Therapeutics was a new Caitong International Asset Management position in Q1 2026.
CAMP4 Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1772 holding.
46 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.